NCT02101125View on ClinicalTrials.gov

Drug Interaction Study With Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Immunosuppression For Disease
Interventions
DRUG

BMS-986020

DRUG

Rosuvastatin

Trial Locations (1)

78209

Healthcare Discoveries, Llc D/B/A Icon Development Solutions, San Antonio

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY